Mylan’s price increases for the allergy treatment device highlight a common tactic in the industry: raising prices just before a generic competitor reaches the market.
ANDREW POLLACK, New York Times
Wed, 08/24/2016 - 5:21pm
Mylan’s price increases for the allergy treatment device highlight a common tactic in the industry: raising prices just before a generic competitor reaches the market.